You are here

  • Home
  • Archive
  • Volume 60, Issue Suppl 1
  • Gene modified cellular vaccine (GMCV) composed of autologous adipose-derived mesenchymal stem cells (AAD-MSCS) transfected with lipid-cation HSP70 activated innate and adaptive immunity after targeting metastatic pancreatic Ca cells

Alerts

Article menu

Download PDFPDF

Oral
Neoplasia and cancer pathogenesis free papers
Gene modified cellular vaccine (GMCV) composed of autologous adipose-derived mesenchymal stem cells (AAD-MSCS) transfected with lipid-cation HSP70 activated innate and adaptive immunity after targeting metastatic pancreatic Ca cells
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address